80岁以上高龄老年骨质疏松症的规范诊治和注意事项

被引:37
作者
边平达
陈锦平
机构
[1] 浙江省人民医院骨质疏松诊疗中心
关键词
骨质疏松症; 诊治; 高龄; 骨密度; 骨转换标志物;
D O I
暂无
中图分类号
R580 [];
学科分类号
摘要
骨质疏松症(OP)是一种以骨量低下、骨微结构破坏,导致骨脆性增加、易发生骨折为特征的全身性疾病。近年来,随着人口老龄化社会的到来,高龄老年OP患者越来越多。高龄老年OP的发生与高龄老人体内性激素(包括雌激素和雄激素)水平下降、营养物质摄入减少、活动量下降、某些疾病等因素有关。高龄老年OP患者不仅脆性骨折的发生率高,而且骨折后容易致残、致死。高龄老年OP诊治的基本内容包括普查和健康教育、选择合适的抗OP药物、及时调整治疗方案等。骨转换标志物(BTMs)的检测是高龄老年OP患者选择抗OP药物的重要依据,一般来说,对BTMs较高的高龄骨量减少和OP患者,应选择使用抗骨吸收药物,如双膦酸盐类和选择性雌激素受体调节剂等,而对BTMs较低的高龄OP患者,应选择使用促骨形成药物(如重组人甲状旁腺激素1-34)。要注意根据高龄老年OP患者骨密度和BTMs的变化,及时调整治疗方案,避免长期使用双膦酸盐类药物。
引用
收藏
页码:757 / 760+768 +768
页数:5
相关论文
共 19 条
[1]
Secondary Prevention After an Osteoporosis-Related Fracture.[J].Joanna E.M. Sale;Dorcas Beaton;Earl Bogoch.Clinics in Geriatric Medicine.2014, 2
[2]
Hip fracture risk factors and the discriminability of hip fracture risk vary by age: A case–control study.[J].Mahesan Anpalahan;Stewart G Morrison;Stephen J Gibson.Geriatrics & Gerontology International.2014, 2
[3]
The association between plasma homocysteine levels and bone quality and bone mineral density parameters in older persons.[J].A.W. Enneman;K.M.A. Swart;M.C. Zillikens;S.C. van Dijk;J.P. van Wijngaarden;E.M. Brouwer-Brolsma;R.A.M. Dhonukshe-Rutten;A. Hofman;F. Rivadeneira;T.J.M. van der Cammen;P. Lips;C.P.G.M. de Groot;A.G. Uitterlinden;J.B.J. van Meurs;N.M. van Schoor;N. van der Velde.Bone.2014,
[4]
Low bone mineral density is associated with balance and hearing impairments [J].
Mendy, Angelico ;
Vieira, Edgar R. ;
Albatineh, Ahmed N. ;
Nnadi, Augustine K. ;
Lowry, Dana ;
Gasana, Janvier .
ANNALS OF EPIDEMIOLOGY, 2014, 24 (01) :58-62
[5]
Recent Advances: Osteoporosis in the "Oldest Old" [J].
Colon-Emeric, Cathleen S. .
CURRENT OSTEOPOROSIS REPORTS, 2013, 11 (04) :270-275
[6]
Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women [J].
Pekkarinen, T. ;
Loyttyniemi, E. ;
Valimaki, M. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (12) :2983-2992
[7]
Objective Measures of Physical Activity, Fractures and Falls: The Osteoporotic Fractures in Men Study [J].
Cauley, Jane A. ;
Harrison, Stephanie L. ;
Cawthon, Peggy M. ;
Ensrud, Kristine E. ;
Danielson, Michelle E. ;
Orwoll, Eric ;
Mackey, Dawn C. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (07) :1080-1088
[8]
How Long Women with Postmenopausal Osteoporosis Should be Treated with a Bisphosphonate?.[J].K. Kerschan-Schindl;J. Haschka;B. Obermayer-Pietsch;R. Gasser;H.-P. Dimai;A. Fahrleitner-Pammer;H. Dobnig;P. Roschger;E. Preisinger;K. Klaushofer;H. Resch;P. Pietschmann.Horm Metab Res.2013,
[9]
Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study [J].
Tamaki, J. ;
Iki, M. ;
Kadowaki, E. ;
Sato, Y. ;
Chiba, Y. ;
Akiba, T. ;
Matsumoto, T. ;
Nishino, H. ;
Kagamimori, S. ;
Kagawa, Y. ;
Yoneshima, H. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (03) :887-897
[10]
Familial resemblance of bone turnover rate in men aged 40 and over-the MINOS study [J].
Nagy, Hoda ;
Feyt, Clement ;
Chapurlat, Roland ;
Szulc, Pawel .
JOURNAL OF BONE AND MINERAL METABOLISM, 2013, 31 (02) :222-230